Significance of Synthetic Biology

Synthetic biology transforms our methods for growing food, what we eat, and where source materials and medicines are sourced. 

Numerous scientists doubt that synthetic biology is not going to reveal advanced knowledge on the lifespan, along with the development of new biotechnological applications. The two primary applications include pharmaceuticals and biofuels. 

For instance, researchers are working on antimalarial drug artemisinin synthetic manufacturing. It is produced naturally in the sweet wormwood plant. Scientists have teased apart the DNA of the plant sequences and protein pathways that produces artemisinin with contents of yeast and bacteria, by utilizing synthetic biology techniques. It boosts synthetic artemisinin production by several 10 million times with the possible output. 

Moreover, considering biofuels, scientists are focusing on developing microbes that can break down the dense feedstocks for biofuel production, including growing, processing, and burning feedstock in a more efficient, cost-effective, and eco-friendly way. 

Synthetic biology can be defined as the redesigning of organisms by engineering them for essential purposes to integrate new abilities. Researchers and companies are working on improving nature's power to resolve potential problems in various sectors, such as manufacturing, agriculture, and medicine. 

Redesigning organisms is done to produce a specific substance which includes medicine, fuel, or developing new abilities, including sensing something in the environment, which are some of the major synthetic biology project goals. 

For instance,

Modification of rice for beta-carotene production is a nutrient associated with carrots which prevents the deficiency of vitamin A. Deficiency of vitamin A causes blindness in 25000 to 500,000 each year, and increases the death risk in children from infectious diseases.

The engineering of yeast for producing rose oil, as is considered an eco-friendly and sustainable substitute for real roses so perfumers can use it to make luxury scents. 

In several ways, synthetic biology is similar to genome editing, as they both include transforming an organism’s genetic code. However, several people can identify the differences between these two approaches on the basis of how change emerged. 

The synthesized DNA pieces could also be genes found in other organisms, as they are wholly novel. 

Synthetic biology often involves scientists stitching together the long DNA stretches and inserting them into the genome of an organism. The genome editing tools can also be used for adding or deleting small DNA stretches in the genome.

The major companies operating in the industry are Merck KGaA, Novozymes A/S, Codexis Inc., Integrated DNA Technologies, Royal DSM N.V., New England Biolabs, Illumina, GenScript Biotech Corporation, and Eurofins Scientific. 

Therefore, the rising application of synthetic biology in the healthcare sector to treat deficiency of various nutrients, and prevent diseases caused by them, leads to their increasing prominence. 

Browse Full Report Synthetic Biology Market Revenue and Demand Forecast 

Read More

3D Bioprinting – How is the Future of the Healthcare Industry Panning Out?

The people who are working in the field of 3D Bioprinting are making new development with every passing day, in the technology as well as in their compression of how it can be put to best use in the real world.

Defining Bioprinting?

The process of 3D bioprinting is an additive manufacturing that makes the use of cells and additional biocompatible materials like “inks”, also called bio-inks, for printing living structures adding on layer-by-layer which mimics the behavior of natural living systems.

This process is more and more used for pharma development and validation of drugs, and in the forthcoming times will be employed for medical applications in clinical surroundings, 3D printed skin grafts, implants, bone grafts, biomedical devices, and even complete 3D printed organs, are all hot topics of bioprinting research.

The Present and Future of 3D bioprinting

Right now, the bioprinting of entirely functional composite internal organs, like heart, kidneys, and livers, is still a decade away as a minimum from being a reality but advancements are taking place in this regard at a rapid rate as a result of current accomplishments in clinical research.

A system of cells, nerves, tissues and structures in a human organ needs to be suitably located with a lot of precision for functionality. From positioning the numerous tiny capillaries in a liver, to printing a heart that beats exactly like a normal heart, it is a hard process which will take a whole lot of time.

While some human body parts are more intricate than others, each piece has its peculiar necessities and issues that require addressing. The assortment of the cell types, accurate materials, and bio-inks must be as accurate just as the blueprint

Furthermore, when one wants to work through all these complexities, it requires the incorporation and input of a number of cutting-edge technologies from more than a few fields like engineering, science, biomaterials, physics, cell biology, and medicine.

Difficult But Opportune Way Ahead

Contempt all these difficulties, the process of bioprinting is quickening at a rapid rate and it is a time, when this field is seeing a lot of potential. The people who are working heart out in are putting their best foot forward in the technology as well as and comprehending that how it can be used for getting the best possible results. While we are still not anywhere close to the product, there is still no doubt in the fact that the future of medicine and healthcare will be pretty different in the years to come, all thanks to the process of bioprinting.

With a high need for organ transplants in the world, increased drug delivery activities and growing elderly population around the world, the demand for 3D bioprinting will reach to a value of about$5,873 million by the year 2030.

Browse Full Report 3D Bioprinting Market Key Market Demand and Growth

Read More

Increasing Prominence of Magnetic Beads in the Clinical Diagnostics

The magnetic beads industry garners $2,835.1 million revenue in 2021, and it is projected to rise by 12.2% from 2021 to 2030, to capture $8,012.0 million revenue in 2030. France generates the highest revenue, in the European industry. It is led by the rising consumption of magnetic beads in in-vitro diagnostics, which involves cell separation, tumor cell removal, and genetic analysis of specific DNA or RNA.

A range of in-vitro diagnostics tests provides crucial medical data for delivering improved healthcare. Such diagnostic tools are used in the whole medical care spectrum, along with risk assessment, illness detection and prognosis, and analyzing the effectiveness of therapy.

Numerous businesses establish themselves in the industry by providing a broad selection of products with a range of technical features. Businesses are focusing on improving production technologies to fulfill client expectations in medication delivery systems, bioresearch, and in-vitro diagnostics, and businesses to improve the production technologies.

The increasing usage of magnetic beads in the life sciences increases the possibility of avoiding centrifugation steps. The growing trend for modification of magnetic beads in lab-on-a-chip systems is seen. It allows the possibility for their manipulation at a distance, without impacting the biochemical reactions.

Moreover, magnetic beads are widely used in immunoassays in the microfluidic format. In biological molecule analysis, these immunoassays are indispensable. Hence, they are explored for a large number of applications.

The detection sensitivity of magnetic beads is increased when they are used for biological molecule analysis, as numerous detectable molecules can be produced with fewer immunocomplexes. The flow of enzyme-substrate through the reaction chamber of the magnetic bead results in the formation of an identical product.

Therefore, the high prominence of magnetic beads in in-vitro diagnostics leads to their rising demand.

Read More

UHT Milk Market Is on Track To Hit $126,174 Million by 2030

The demand for ultra-high temperature (UHT) milk, sometimes referred to as long-life milk, has a lot of room for expansion. One main factor driving UHT milk sales is the growing habit of consuming milk on the move.

UHT Milk Market Revenue Estimation and Growth Forecast Report

Due to their increasingly hectic schedules, people nowadays are forced to look for alternatives to regular liquid milk, which must be refrigerated and has a finite shelf life.

Get More Insights: UHT Milk Market Revenue Estimation and Growth Forecast Report

By 2030, the UHT milk market will be worth $126,174 million. This is attributable to increased knowledge of this product, which urban young prefer owing to its busy lifestyles, extended shelf life, and ease of use.

Due to its perishable nature, regular milk consumption is declining in both developed and developing countries' metropolitan areas. The ultra-heated milk is used worldwide as an alternative to traditional milk.

The rise in the number of individuals with hectic schedules and the absence of refrigeration facilities in growing nations are the two main drivers of the worldwide industry.

Whole Milk IS Most Popular

The most popular type of milk is whole milk, often known as full-cream milk, and it is normally sold with a fat content of 3.5% or more. This group occupied about 60% of the market. Whole milk is beneficial throughout the formative years because it contains high phosphorus, calcium, and vitamins B1, A, and D.

Due to its great nutritional content, it is primarily ingested by youngsters, teens, nursing moms, and bodybuilders. Whole milk is often used in restaurants and coffee shops since there is a great need for milk with a significant whipping quality.

One of the key drivers of the industry is a scarcity of refrigerated space. Food items that are more prone to bacterial growth need to be refrigerated. Raw milk needs to be kept cold until it's eaten.

Because of the high cost of refrigeration, the scarcity of chilled space, and the protracted power outages, consumers are more prone to use goods that endure a long time without refrigeration in developing countries.

Growing Consumer Demand for Full-Fat UHT Milk

When alternative methods are insufficient, whole milk and cream are subjected to UHT treatments.

For instance, while making whole milk, the cream portion contains fat globules that cannot pass via the microfiltration membrane—it is the first UHT treated before being combined with the microfiltered skim milk to create a product with a longer shelf life.

Toddlers best consume full-cream UHT milk under 2 years old, expectant mothers, and bodybuilders since it contains much more fat than semi-skimmed and skimmed UHT milk.

Direct and Institutional Sales Will Surge

The direct/institutional category will have the greatest CAGR in the coming years. This is a result of rising sales at government agencies and restaurant franchises. Restaurant chains are starting to emerge as important clients to satisfy the milk industry demand, particularly for variations with a larger whipping capacity.

Read More

How Does Rising Demand for Security Enforcement Propels Ballistic Protection Industry?

The ballistic protection industry has garnered $12,478.08 million revenue, and it is projected to generate $19,378.54 million revenue in 2030, advancing at a rate of 5.01%. It is led by the surging use of ballistic protective materials in law and military enforcement organizations across the world. It is ascribed to protecting law enforcement personnel, military personnel, and vehicles from projectiles, mortars, mines, explosives, falling glass, and other dangerous materials.

In addition, these protective materials function in a different way, usually when they are struck by bullets or explosives.

Moreover, the rise in the homeland security forces, such as police, VIP security staff, and first responders, along with the rise in the defense budget boosts the industry growth. Also, governments focus on proliferating and protecting military capabilities due to increasing cross-border disputes.

North America captures the largest industry share of the industry. It is led by rising demand for lightweight armor, surging R&D expenditure, technical advancements, and the presence of key players. The major industry players offer ballistic protection solutions, which include helmets, vehicle armor, shields, and uniforms.

Moreover, celebrities, political leaders, and other famous individuals select private security services, led by increasing security threats, growing terrorist attacks, and cross-border conflicts leading to the increasing requirement for ballistic protection in the Canada and U.S.

On the other hand, the APAC industry is projected to experience rapid growth in the coming years. It is ascribed to increasing defense expenditure in countries such as China, India, Australia, South Korea, and Japan, including the growing economy of the region.

In addition, governments of the above-mentioned countries focus on partnering with the contractors and providing them assistance in the procurement process with financial support and infrastructure.

Therefore, the rising security concerns and growing demand for improving army survivability boost the demand for ballistic protection.

Read More

Rising Prevalence of Gastro-Intestinal Diseases Boosts Microbiome Therapeutics Industry

The microbiome therapeutics industry has garnered $314.4 million revenue in 2021, and it is projected to rise at the rate of 23.1% in the coming years, to capture the $2,036.4 million industry size.

The microbiome plays a substantial role in both types of illnesses gastrointestinal, and non-gastrointestinal, making it a lucrative target for new therapies. In addition, industry growth is ascribed to the potential of digestive-related therapeutics to mitigate the inadequacies in traditional treatment.

There is a higher possibility of such therapeutics to cater to the demand of present therapeutics choices, rise in the illness dimension, participation of academic institutions, rising strategic activities, and recognizing the businesses operating in the field.

Opportunities in the Industry

The presence of innovative players in a smaller number provides numerous opportunities to grow for major stakeholders and attain businesses that involve studying microbiomes for discovering new drugs and drug targets for multiple indications, such as liver disorders, obesity, metabolic disorders, and diabetes.

The key industry players are focusing on strategic alliances and collaborations to expand themselves through product pipelines with efficient R&D methods. In addition, numerous companies have participated in collaborations and partnerships in the last two years, to remain on the competitive edge.

Businesses reduce the selling price of goods and extend state-of-the-art healthcare access to a wider populace section, to propel the usage of digestive health-related therapies. It offers vendors alluring opportunities for growth.

The fecal microbial transplant captures a substantial share of the industry revenue, and it is projected to capture over 84% of the revenue share in 2030. It is owed to the rising fecal microbial transplant usage and the presence of FMT in the capsule form, that has increased the acceptability of the C. difficile infection treatment for patients.

Moreover, the microbiome drugs demand is expected to rise at a higher rate in the coming years. It is led by the rising research activities conducted by research institutes to discover the additional therapeutic FMT uses, a strong pipeline, and the development of advanced medications.

Microbiome therapeutics contribute to gastrointestinal and infectious disease treatment. It contributes more than 92% of the industry share. Moreover, a slew of such treatments focuses on gut-relevant disorders, such as inflammatory bowel disease, C. diff. infection (CDI), and ulcerative colitis, are in the developmental stage and offer massive economic potential in the coming years.

Get More Details Microbiome Therapeutics Market Share

Read More

Why Do We Need Medical Device Analytical Testing Outsourcing?

Several companies of medical devices outsource analytical testing tasks to reduce the costs, hasten the launch of novel products into the analytical testing outsourcing business, and eliminate commercial risks. 

IMDs, or implantable medical devices, are being used more often to improve patient outcomes in terms of health. The balance between complexity, power consumption, reliability, and cost must be struck by IMD designers.

The global demand for medical device analytical testing outsourcing is growing due to the government's increasingly stringent quality certificate regulations. Medical device manufacturers are engaging consultants to assist them in understanding the paperwork and legal requirements for pre-market approval.

The demand for medical device analytical testing outsourcing is predicted to hit $10,904.8 million by 2030. This is due to an increase in the number of small-scale producers of medical devices, increased demand for medical device efficacy and security verification and validation, and the implementation of stringent government regulations.

Increasing Number of Cardiovascular Diseases

Due to the rising frequency of heart problems, there is a high requirement for cardiovascular equipment, which is why outsourcing is expanding. It is estimated that more than 17 million people die each year from cardiovascular diseases. That figure will increase to 23.6 million by 2030.

Moreover, CVDs are quite complex, requiring the safest and most user-friendly diagnostic and therapeutic tools imaginable.

To expand production and outsource the analytical testing process, medical device companies are turning to contract development and manufacturing organizations, along with a growth in the number of patients.

Reprocessed Devices: Why Are They So Popular?

Cleaning up any visible debris, properly sanitizing the equipment, packaging and labeling it, and ultimately holding the reprocessor accountable for any unfavorable effects the item may have been all steps in the reprocessing process.

Even though medical device reprocessing is still relatively new globally, it has already been demonstrated to provide healthcare professionals with several significant benefits.

Orthopedic blades, fixation tools, endotracheal tubes, electrosurgical electrodes, electrophysiology catheters, and ophthalmic knives may all now be recycled in large quantities.

Why Do Hospitals Contract Out Testing for Analyses?

Hospitals' increasing need for medical devices built with emerging technology is a significant factor pushing the use of analytical testing for medical devices among hospitals. These facilities store cutting-edge medical technologies that require thorough analysis and testing to work at their best.

Hospitals are one of the most important target industries for contract development and manufacturing organizations since they are the principal consumers of refurbished medical equipment, which necessitates analytical services.

Get More Details Medical Device Analytical Testing Outsourcing Market Competitive Landscape

Read More